STOCKSCREENR

0RNK.L

LSE

Inventiva S.A.

$4.27+0.07(+1.67%)Mkt Cap: $593.11M

Key Stats

Market Cap

$593.11M

P/E Ratio

-3.37

EPS

$-1.27

Dividend Yield

0.00%

52-Week Range

$1.92 — $4.75

Volume

12.95K

Avg Volume

1.96K

Beta

0.95

Price Alerts for 0RNK.L

Get alerted when 0RNK.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-3.37

Forward P/E

—

PEG Ratio

-0.18

P/S (TTM)

147.03

P/B (TTM)

-105.88

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

18.70%

ROA (TTM)

-1.42%

ROIC

—

Gross Margin

0.35%

Operating Margin

-30.37%

Net Margin

—

Debt/Equity

-2.10

Current Ratio

3.16

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.38%

EPS Growth (5Y)

-0.24%

Sales Growth (3Y)

+0.73%

Sales Growth (5Y)

+2.30%

EPS Est (This Year)

$-0.66

EPS Est (Next Year)

$-0.63

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.36

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

139.06M

Float

92.85M

Free Float %

66.77%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

FR

Exchange

LSE

IPO Date

2017-03-30

Employees

114

CEO

Andrew Obenshain

Index Membership

—

Website

https://www.inventivapharma.com

Inventiva S.A. (0RNK.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $593.11M, a P/E ratio of -3.37, 0RNK.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0RNK.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0RU5.L

Oncoinvent ASA

$49.50

+3.13%

$1.94B

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0L35.L

Sarepta Therapeutics, Inc.

$21.09

+2.59%

$2.11B

LFMD

LifeMD, Inc.

$4.68

+5.64%

$224.52M

0IMT.L

Photocure ASA

$65.10

-4.41%

$1.73B

0QLN.L

Tecan Group AG

$117.70

+1.90%

$1.48B

Frequently Asked Questions

What is Inventiva S.A.'s P/E ratio?

Inventiva S.A. (0RNK.L) has a trailing twelve-month (TTM) P/E ratio of -3.37. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Inventiva S.A. pay a dividend?

No, Inventiva S.A. (0RNK.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Inventiva S.A.'s market cap?

Inventiva S.A. (0RNK.L) has a market capitalization of $593.11 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.